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Background: Clostridium butyricum has become increasingly important in preventing and treating intestinal
inflammation. In the intestine it may increase the resistance of the gut to pathogen invasion via inducing the
secretion of anti-inflammatory cytokines. Interleukin 10 (IL-10) plays a central role in preventing certain
inflammatory diseases by down-regulating inflammatory cascades. In a previous study, we observed that the level
of IL-10 mRNA was modulated by C. butyricum. The aim of this study was to investigate whether C. butyricum
achieves its beneficial effects through IL-10.
Results: We treated HT-29 cells with anti-IL-10 (IL-10 antibody) or siIL-10 (IL-10 small interfering RNA) to disrupt
IL-10. In both cases, the effects of C. butyricum-induced NF-κB activation and IL-8 expression were enhanced. We
also found that neutralization or knockdown of IL-10 could induce apoptosis and necrosis of HT-29 cells treated
with C. butyricum compared with control cells.
Conclusions: These findings show that IL-10 serves an important role in C. butyricum-mediated immune protection,
and in host recognition of C. butyricum.Background
Probiotic bacteria are live microorganisms which are
beneficial to the host organism, and can exert health
benefits beyond those of inherent basic nutrition. A re-
cent study indicates that the use of probiotics is rapidly
advancing from the field of nutrition towards thera-
peutic applications [1]. Probiotics have proven useful in
preventing and treating diarrhea. Crohn’s disease and ul-
cerative colitis patients exhibit loss of immune tolerance
to enteric bacteria. Probiotics have modest but consist-
ent prophylactic efficacy and can regulate innate and
adaptive immunity to enhance innate defenses against
microbes and maintainimmune homeostasis [2,3].
Therefore, immune modulation and inhibition of exces-
sive immune response and inflammation are proposed
to be mechanisms of action of probiotics [4,5].* Correspondence: wjb@nit.zju.edu.cnfs
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reproduction in any medium, provided the orIt has been demonstrated that IL-10 plays a crucial
role in down-regulating inflammatory cascades by sup-
pressing the secretion of pro-inflammatory cytokines.
IL-10-deficient mice develop chronic intestinal inflam-
mation, which is in part caused by a loss of suppression
of the mucosal immune response toward normal intes-
tinal bacteria [6]. Recent studies have reported that top-
ical treatment with IL-10 is effective in preventing
certain inflammatory diseases. Moreover, probiotics can
exert a therapeutic effect mediated through an IL-10-
dependent mechanism [7]. It has been shown that oral
administration of probiotics can prevent inflammation
and mucosal ulcerations, which are associated with up-
regulation of IL-10, which inhibits the increase of the
CD4+ helper T cell population and down-regulates in-
flammatory cytokines [8].
Probiotics can exert immunomodulatory activities by
increasing IL-10 production, which can in turn help pre-
vent an excessive immune response. However, probiotic
bacteria have multiple and diverse effects in the host,
and not all probiotic strains act in this manner. The C.
butyricum MIYAIRI II 588 stain has been used to. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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enhance the humoral immune response in the human
intestine [9]. However, the mechanisms by which C.
butyricum treats and prevents diarrhea remain unclear.
The aim of the present study was to assess whether C.
butyricum achieves its beneficial effects via modulation
of IL-10 production.
Methods
Bacterial strains and culture conditions
C. butyricum MIYAIRI II 588 used in this study was
obtained from Miyarisan Pharmaceutical Co. Ltd, Tokyo,
Japan. This strain is a butyric-acid producing, spore-
forming and gram-positive rod bacterium [10]. It was
cultured in MRS broth at 28°C in an anaerobic
environment.
Cell culture
HT-29 human colonic epithelial cells were purchased
from the cell bank of the type culture collection of the
Chinese academy of sciences (Shanghai). Enterocyte-like
HT-29 cells were cultured in RPMI 1640 medium sup-
plemented with 10% heat-inactivated fetal bovine serum,
100 U ml−1 penicillin, and 100 μg ml−1 streptomycin at
37°C in a humidified atmosphere of 5% CO2.
SiRNA transient transfection
One day before transfection, HT-29 cells (1 × 106 cells
well−1) were allowed to attach and grow in 6-well culture
plates (Corning, USA). When the plated cells in medium
without antibiotics were 30–50% confluent, IL-10-
specific siRNA (small interfering RNA) synthesized by
Ribobio (Guangzhou, China) was transfected into cells
with Lipofectamine 2000 (Invitrogen). After 48 h, cells
were treated with C. butyricum and assayed for transfec-
tion efficiency by real-time PCR.
IL-10 neutralization
IL-10 antibody-blocking was performed as described
previously [11]. To prevent the effects of IL-10, superna-
tants were treated with IL-10 antibody (5 μg ml−1;
HuaAn, China). These treated cells were then cultured
in 6-well plates at 1 × 106 cell well−1. After 48 h, the cells
were stimulated with C. butyricum.
Stimulation of cells
Before stimulation assays, the bacteria were collected
and re-suspended in antibiotic-free 1640 media. To in-
vestigate whether C. butyricum regulates IL-10 expres-
sion in HT-29 cells, the cells were exposed to 1 × 106,
1 × 107, 1 × 108 CFU ml−1 of C. butyricum for 2 h. The
culture media were collected and analyzed for IL-10 by
an enzyme-linked immunosorbent assay (ELISA), andthe same cells from the original culture medium were
harvested for real-time PCR analysis.
HT-29 cells pretreated with IL-10 antibody or siIL-10
were treated with 2 ml 1640 media or C. butyricum sus-
pensions at designated concentration (1× 108 CFU ml−1),
and incubated for 2 h. The culture media were collected
and analyzed for IL-8 and IL-10 by ELISA, and the same
cells from the original culture medium were harvested for
real-time PCR and western blot analysis. In addition, we
also detected the morphology of apoptotic cell nuclei
using the PI method.
Determination of IL-8 secretion using a sandwich ELISA
Human IL-8 proteins were assayed using BlueGene
ELISA Kits, according to the manufacturer’s instructions
(BlueGene Biotechnology, Shanghai, China).
Western blot analysis for NF-κB (p50/105) and IκB
expression
Total cellular and nuclear proteins were extracted
according to the instructions of the nuclear and cyto-
plasmic protein extraction kit (Beyotime, Haimen,
China). The nuclear extracts were used to determine
NF-κB protein levels and the cytoplasmic extracts were
used to determine IκB levels. The protein content of the
lysates was estimated using an enhanced BCA protein
assay kit (according to the manufacturer’s instructions).
Fifty micrograms of protein from each sample were sub-
jected to SDS-PAGE. After electrophoresis, proteins
were electro-blotted to a Hybond-C Extra nitrocellulose
membrane (Amersham, USA). The membrane was
blocked at room temperature with 5% non-fat dry milk
in TBS containing 0.3% Tween (TBS-T). The membrane
was washed thrice with TBS-T and incubated overnight
at 4°C with the primary antibody, anti-NF-κB (1:2000),
anti-IκB (1:2500) and anti-β-actin (1:3000). This was fol-
lowed by 1 h incubation with a 1:5000 dilution of the ap-
propriate horseradish-peroxidase-conjugated secondary
antibody. After incubation, the membrane was washed
with TBS-T thrice. The antigen-antibody complexes
were visualized by enhanced chemiluminescence and
exposed to X-ray film for between 0.5 and 30 min [12].
Real-time quantitative PCR
The cells were harvested and washed with ice-cold PBS.
Total RNA was extracted using an RNATMiso PLUS Kit
(Takara Biotechnology, Dalian, China). The RNA was re-
verse transcribed into complementary DNA (cDNA)
using PrimeScript 2st Strand cDNA Synthesis Kit
(Takara Biotechnology, Dalian, China). Real-time cDNA
amplification was performed using the SYBR Premix EX
TaqTM (Takara Biotechnology, Dalian, China). cDNA
was then diluted 1:10 in RNase-free, diethyl
pyrocarbonate-treated water. Table 1 shows the primers
Table 1 Oligonucleotide primers used to amplify RNA
transcripts
Primers Forward primer (5′ to 3′) Reverse primer (5′ to 3′)
β-actin CTA CAA TGA GCT GCG TGT GG TAG CTC TTC TCC AGG
GAG GA
IL-8 ATG ACT TCC AAG CTG GCC
GTG GCT
TCT CAG CCC TCT TCA AAA
ACT TCT C
IL-10 ATG CCC CAA GCT GAG AAC
CAA GAC CCA
TCT CAA GGG GCT GGG TCA
GCT ATC CCA
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was carried out in 25.0 μl end volume containing 2 μl
cDNA, 12.5 μl 2 × SYBR Premix EX TaqTM, 0.5 μl ROX
Reference DyeII, 9 μl dH2O, and 10 μM of each primer.
The amplification reactions were performed under the
following PCR conditions: (i) one cycle at 95°C for 30 s,
(ii) amplification including 40 cycles of 95°C for 10 s, 60°
C for 20 s, (iii) 95°C for 30 s, 55°C for 1 min, 95°C for
30 s. The data represent mean values obtained in three
independent experiments performed in duplicate.
Propidium Iodide (PI) assay
Morphology of apoptotic cell nuclei was detected by
staining with the DNA binding fluorochrome PI (Beyo-
time Institute of Biotechnology, Jiangsu, China). The nu-
clei of apoptotic and necrosis cells were observed using
fluorescence microscopy [13].
Caspase-3 activity assay
The activity of caspase-3 was determined using the
Caspase-3 activity Kit (Beyotime Institute of Biotechnol-
ogy, Jiangsu, China). Cell lysates were prepared by incu-
bating 2 × 106 cells ml−1 in extraction buffer for 15 min
on ice. After centrifugation at 20,000 × g for 15 min at 4°
C, the supernatants were collected. In a 100 μl reaction
volume, 10 μl sample or buffer (blank) were incubated
with the substrate Ac-DEVD-pNA (acetyl-Asp-Glu-Val-
Asp p-nitroanilide) in a 96-well microplate for 2 h at 37°
C. The optical absorbance was measured at 405 nm
using a microplate reader (A-5082, TECAN, Austria).
Caspase-3 activity was expressed as the percentage of
enzyme activity compared with the control [14].
DNA fragmentation analysis
DNA was extracted using a DNA ladder extraction kit
with spin column (Beyotime Institute of Biotechnology,
Jiangsu, China). 10 μl of the DNA sample was separated
on a 1.0% agarose gel and the DNA band pattern was
visualized [14].
Statistical analysis
All statistical analyses were performed using Statistical
Analysis System software (SAS V8). All results areshown as the average of more than three replicates. Data
are presented as mean ± the standard error (SE). Dun-
can’s multiple range tests were used to evaluate the stat-
istical significance of the results. Differences with p
values of< 0.05 were considered significant.
Results
C. butyricum stimulates elevated levels of IL-10 in HT-29
cells
To investigate whether C. butyricum regulates IL-10 ex-
pression in HT-29 cells, a stimulation assay was per-
formed, as described in the methods. Figure 1A shows
that IL-10 concentrations in the media of HT-29 cells
cultured with C. butyricum were increased significantly.
The same cells from the culture media were collected,
and subjected to real-time PCR assay. In this case, IL-10
mRNA levels were also enhanced significantly by C.
butyricum (Figure 1B). The correlation between the level
of C. butyricum and IL-10 production or IL-10 mRNA
expression was dose-dependent.
Neutralization of IL-10 released by HT-29 cells enhances
the effects of C. butyricum-induced NF-κB activation and
IL-8 expression
Our previous study demonstrated that C. butyricum could
induce HT-29 cells to release low levels of pro-
inflammatory cytokines, which is similar to other probio-
tics such as Lactobacilli [15]. We also found that C. butyr-
icum could increase the expression of anti-inflammatory
cytokines, which may be associated with the beneficial
properties of C. butyricum. In the current study, we have
shown that C. butyricum can induce HT-29 cells to se-
crete IL-10. To determine whether this IL-10 present in
culture supernatant affects the C. butyricum-induced im-
mune response in HT-29 cells, an IL-10 antibody was uti-
lized to treat HT-29 cells. Neutralization of IL-10 using
anti-IL-10 for 48 h resulted in a significant degradation of
cytoplasmic IκB protein and an increase in nuclear NF-κB
and supernatant IL-8 levels (Figure 2). Therefore, it can be
concluded that down-regulation of inflammatory cyto-
kines and inhibition of excessive immunity in HT-29 cells
induced by C. butyricum is probably mediated through
IL-10.
Knockdown of IL-10 enhances the effects of C. butyricum-
induced NF-κB activation and IL-8 expression
To further confirm the effects of IL-10 on the activation of
NF-κB and secretion of IL-8, NF-κB, IκB and IL-8 levels
were measured after pre-treating HT-29 cells with siNEG
(negative control-specific siRNA) or siIL-10 (IL-10 small
interfering RNA) for 48 h, and then treating them with C.
butyricum for 2 h. The transfection of HT-29 cells with
siRNA specific to IL-10 caused a significant reduction in
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Figure 1 IL-10 mRNA expression and IL-10 protein secretion were stimulated by C. butyricum. The cells were exposed to 1 × 106, 1 × 107,
1 × 108 CFU ml−1 of C. butyricum for 2 h. (A) At the end of the incubation period, cell culture supernatants were collected to determine IL-10
protein concentration by sandwich ELISA. (B) The same cells were harvested for real-time quantitative PCR. Data represent the mean± the
standard error of the mean for three experiments. *, P< 0.01 compared with the control. C: levels of IL-10 in control HT-29 cells.
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IL-10 knockdown caused IκB degradation, NF-κB activa-
tion and increase in IL-8 expression (Figure 3B, C, D).
These data confirmed our suggestion that C. butyricum

























Figure 2 Activation of NF-κB and up-regulation of IL-8 expression in
IL-10 antibody. (A) Immunoblot showing levels of NF-κB (p50/p105 subun
response to C. butyricum in control and anti-IL-10 treated cells. (C) IL-8 tran
three experiments. *, P< 0.01 compared to the control without IL-10 antib
control HT-29 cells. T: levels of NF-κB, IκB or IL-8 in HT-29 cells treated withDisruption of IL-10 induces apoptosis and necrosis of HT-
29 cells with C. butyricum
The induction of apoptosis in intestinal epithelial cells
by bacteria is well reported, and it may assist infection
by pathogens [16]. The process of apoptosis is controlled
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Figure 3 SiRNA silencing of IL-10 enhances C. butyricum-induced NF-κB activation and IL-8 secretion. HT-29 cells were transfected with
siNEG (negative control-specific siRNA) or IL-10-specific siRNA for 48 h prior to stimulation. RNA was extracted after a 2 h C. butyricum treatment,
and the levels of IL-10 (A) and IL-8 (B) were measured by real-time PCR. (C) IL-8 secretion in response to C. butyricum in siNEG control and IL-10
knockdown cells. (D) Immunoblot shows levels of NF-κB and IκB in cells with 20 nM IL-10 siRNA compared with the control. Results are
mean± SE for three experiments. C: levels of NF-κB, IκB or IL-8 in control HT-29 cells. T: levels of NF-κB, IκB or IL-8 in HT-29 cells treated with C.
butyricum. *, P< 0.01 compared to the respective siNEG controls.
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of up-regulated NF-κB and IL-8 levels by disruption of
IL-10, cell apoptosis and necrosis were observed after
DAPI (4′,6-diamidino-2-phenylindole) and PI staining.
DAPI is a fluorescent strain for labeling DNA that is
commonly used to visualize nuclei and mitochondria. It
can pass through an intact cell membrane, and can
therefore be used on live or fixed cells. Apoptosis in late
stage and necrosis can be detected using PI straining. A
significant increase in the number of PI-positive cells
(abnormal nuclei contents) in cells treated with IL-10
antibody or siIL-10 compared with the control was
observed (Figure 4A). Furthermore, the activity of
caspase-3 was also significantly increased (Figure 4B). In
addition, DNA fragmentation was induced in the IL-10
antibody or siIL-10 treated cells (Figure 4C). These
results indicate that lack of IL-10 can induce excessive
immunity and even cell death in HT-29 cells.
Discussions
The intestinal epithelial cell surface represents the lar-
gest exposed surface of the body that must be protected
by the immune system against toxic substance and
pathogenic bacteria. All intestinal epithelial cells are usu-
ally capable of regulating the immune response throughdifferent mechanisms, one of which is the secretion of
anti-inflammatory cytokines. Throughout the present
study, we have focused on the role of IL-10 in regulating
epithelial cell function. IL-10 is a potent inhibitor of
pro-inflammatory cytokine production, and has been
shown to inhibit production of IL-6 and IL-1β in macro-
phages [18,19]. Supporting evidence for a role for IL-10
in inflammation is derived from studies in mice deficient
in IL-10 or harboring mutated IL-10, which are a model
of enterocolitis [20]. These IL-10−/− mice under normal
conditions show increased inflammatory responses and
develop inflammatory bowel disease. Moreover, these IL-
10−/− mice are extremely susceptible to infection-
induced immunopathology [21]. All these data suggest
that endogenous IL-10 synthesis plays an important role
in vivo in down-regulating immune responses and pre-
venting host immunopathology. Moreover, beneficial
effects in colitis patients have been obtained via pro-
biotic bacteria-induced IL-10 production [22].
In our current study, C. butyricum stimulates elevated
levels of IL-10 in HT-29 cells. Because this probiotic
strain is frequently used in the management of allergic
diseases or gastroenteritis, it is hypothesized that it pro-
motes mucosal tolerance mediated through IL-10.
Therefore, we further assessed the role of IL-10 in




































Figure 4 Disruption of IL-10 induces apoptosis and necrosis of HT-29 cells treated with C. butyricum. IL-10 antibody or siIL-10 treated cells
were stimulated by C. butyricum. (A) After a 2 h incubation, cells were stained with DAPI and PI. Left: staining with DAPI; middle: PI
immunocytochemistry; Right: merge of the two stains. A1, A2 and A3 indicated HT-29 cells of the control, IL-10 antibody and siIL-10 treated
groups respectively. (B) Caspase-3 activation was measured using the chromogenic substrate Ac-DEVD-Pna. (C) DNA fragmentation was detected
using 1.0% agarose gel electrophoresis. M: 2,000 bp ladder markers. Control: the cells treated with C. butyricum.
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or knocking down IL-10 in HT-29 cells. It was found
that disruption of IL-10 enhanced effects of C. butyri-
cum-induced NF-κB activation and IL-8 secretion. The
results demonstrate that C. butyricum modifies the mu-
cosal immune response to modulate the levels of specific
molecules such as cytokines by increasing IL-10 levels
and consequently decreasing inflammatory cytokines.
The viability of cells is dependent on cytokines. How-
ever, high-dose cytokines can induce apoptosis and necro-
sis. Bacteria and their metabolites can induce an anti-
proliferative effect through induction of apoptosis [23-25].
In the current study, disruption of IL-10 enhanced C.butyricum-induced IL-8 secretion. We further assessed
whether this probiotic strain induced apoptosis and necro-
sis of HT-29 cells due to a lack of effect of IL-10. The
results showed that the number of abnormal cells signifi-
cantly increased compared to the control, indicating that
disruption of IL-10 caused a loss of suppression of the
mucosal immune response and even excessive apoptosis
and necrosis. This study confirmed that C. butyricum
exerts anti-inflammatory effects and enhances tolerance
to bacteria through increasing IL-10 production. More-
over, some subsets of Crohn’s disease patients are actually
deficient in the production of IL-10, and therefore in this
subset this probiotic therapy may be of limited use.
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has resulted in the establishment of commensal rela-
tionships where neither partner is disadvantaged, or
symbiotic relationships where both partners benefit
[26]. In our current study, intestinal epithelial cells can
secrete IL-10 to down-regulate inflammatory cascades
through suppressing the secretion of pro-inflammatory
cytokines. On the other hand, C. butyricum can drive
the secretion of IL-10 to enhance tolerance to bacteria.
Such mechanisms allow the host to recognize symbi-
otic bacteria without eliciting a deleterious immune re-
sponse, and enable the symbiotic bacteria to reside in
the gut, thus providing unique metabolic traits or other
benefits. This pathway may be part of an evolutionarily
primitive form of adaptive immunity.
Conclusions
When HT-29 cells were pretreated with anti-IL-10 or
siIL-10, C. butyricum induced an excessive immune re-
sponse and even apoptosis and necrosis compared with
control cells. These findings show that C. butyricum
achieves its beneficial effects on immune modulation
through IL-10. On the other hand, C. butyricum may
have limited usefulness when the host is deficient in the
production of IL-10; this requires further clarification.
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